(Q45872881)

17 December 2017

title

MMAC1/PTEN inhibits cell growth and induces chemosensitivity to doxorubicin in human bladder cancer cells (English)

1 reference

17 December 2017

0 references

1 reference

1 reference

M Tanaka

1

1 reference

17 December 2017

D Koul

2

1 reference

17 December 2017

M A Davies

3

1 reference

17 December 2017

M Liebert

4

1 reference

17 December 2017

P A Steck

5

1 reference

17 December 2017

H B Grossman

6

1 reference

17 December 2017

language of work or name

English

0 references

publication date

1 November 2000

1 reference

17 December 2017

published in

Oncogene

1 reference

17 December 2017

volume

19

1 reference

17 December 2017

issue

47

1 reference

17 December 2017

page(s)

5406-5412

1 reference

17 December 2017

Mechanism of activation and function of protein kinase B.

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203918

Somatic mutation of PTEN in bladder carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203918

Point mutation and homozygous deletion of PTEN/MMAC1 in primary bladder cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203918

The treated natural history of high risk superficial bladder cancer: 15-year outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203918

New approaches in the treatment of metastatic transitional-cell cancer of the bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203918

Adenovirus-mediated p53 gene therapy has greater efficacy when combined with chemotherapy against human head and neck, ovarian, prostate, and breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203918

Natural history of superficial bladder tumors: 10- to 20-year follow-up of treated patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203918

Assessment of in vitro lymphokine activated killer (LAK) cell activity against renal cancer cell lines and its suppression by serum factor using crystal violet assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203918

Multidrug resistance-associated protein-mediated multidrug resistance modulated by cyclosporin A in a human bladder cancer cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203918

Alterations of PTEN/MMAC1, a candidate tumor suppressor gene, and its homologue, PTH2, in small cell lung cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203918

PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203918

Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203918

The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203918

Germline mutations in PTEN are present in Bannayan-Zonana syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203918

Non-P-glycoprotein-mediated atypical multidrug resistance in a human bladder cancer cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203918

Germline mutations in the PTEN/MMAC1 gene in patients with Cowden disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203918

Novel combination therapy for human colon cancer with adenovirus-mediated wild-type p53 gene transfer and DNA-damaging chemotherapeutic agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203918

Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203918

The Uptake and Efflux of Doxorubicin by a Sensitive Human Bladder Cancer Cell Line and Its DoxorubicinResistant Subline

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203918

New approaches in the use of radiation therapy in the treatment of infiltrative transitional-cell cancer of the bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203918

Inactivation of the tumor suppressor PTEN/MMAC1 in advanced human prostate cancer through loss of expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203918

Expression of MDR-1 Gene in Transitional Cell Carcinoma and its Correlation with Chemotherapy Response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203918

Effect of glutathione and its related enzymes on chemosensitivity of renal cell carcinoma and bladder carcinoma cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203918

7 January 2021

Frequent loss of heterozygosity on chromosome 10q in muscle-invasive transitional cell carcinomas of the bladder

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203918

7 January 2021

This month in investigative urology: Immunotherapy of bladder cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203918

7 January 2021

Review of chromosome studies in urological tumors. II. Cytogenetics and molecular genetics of bladder cancer.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203918

7 January 2021

Evaluation of multiple drug resistance in human bladder cancer cell lines.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203918

7 January 2021

The Cowden syndrome: a clinical and genetic study in 21 patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203918

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1203918

1 reference

17 December 2017

Dimensions Publication ID

1000301719

0 references

1 reference

17 December 2017